Page 65 - Demo

www.psypharma.ru %u0421%u043e%u0432%u0440%u0435%u043c%u0435%u043d%u043d%u0430%u044f %u0442%u0435%u0440%u0430 %u043f%u0438%u044f %u043f%u0441%u0438%u0445%u0438%u0447%u0435%u0441%u043a%u0438%u0445 %u0440%u0430 %u0441%u0441%u0442%u0440%u043e%u0439%u0441%u0442%u0432 %u2116 4/2024%u041c%u0435%u0434%u0432%u0435%u0434%u0435%u0432 %u0412.%u042d.65%u041d%u041e%u0412%u042b%u0415 %u041b%u0415%u041a%u0410%u0420%u0421%u0422%u0412%u0415%u041d%u041d%u042b%u0415 %u0421%u0420%u0415%u0414%u0421%u0422%u0412%u041043. Stein D.J., Ahokasy A.A., de Bodinat Ch. Efficacy of agomelatine in generalized anxiety disorder: A randomized, double-blind, placebo-controlled study // J Clin Psychopharmacol. %u2013 2008. %u2013 Vol. 28 (5). %u2013 Pp. 561%u2013566. %u2013https://doi.org/10.1097/JCP.0b013e318184ff5b43. Stein D.J., Ahokasy A.A., de Bodinat Ch. Efficacy of agomelatine in generalized anxiety disorder: A randomized, double-blind, placebo-controlled study // J Clin Psychopharmacol. %u2013 2008. %u2013 Vol. 28 (5). %u2013 Pp. 561%u2013566. %u2013 https://doi.org/10.1097/JCP.0b013e318184ff5b44. Stein D.J., Ahokas A., Albarran C., Olivier V., Allgulander C. Agomelatine prevents relapse in generalized anxiety disorder: A 6-month randomized, double-blind, placebo-controlled discontinuation study // J Clin Psychiatry. %u2013 2012. %u2013 Vol. 73 (7). %u2013 Pp. 1002%u20131008. %u2013https://doi.org/10.4088/JCP.11m0749344. Stein D.J., Ahokas A., Albarran C., Olivier V., Allgulander C. Agomelatine prevents relapse in generalized anxiety disorder: A 6-month randomized, double-blind, placebo-controlled discontinuation study // J Clin Psychiatry. %u2013 2012. %u2013 Vol. 73 (7). %u2013 Pp. 1002%u20131008. %u2013https://doi.org/10.4088/JCP.11m0749345. Stein D.J., Khoo J.P., Picarel-Blanchot F., Olivier V., van Ameringen M. Efficacy of agomelatine 25%u201350 mg for the treatment of anxious symptoms and functional impairment in generalized anxiety disorder: A meta-analysis of three placebo-controlled studies // Adv Ther. %u2013 2021. %u2013 Vol. 38 (3). %u2013 Pp. 1567%u20131583. %u2013https://doi.org/10.1007/s12325-020-01583-945. Stein D.J., Khoo J.P., Picarel-Blanchot F., Olivier V., van Ameringen M. Efficacy of agomelatine 25%u201350 mg for the treatment of anxious symptoms and functional impairment in generalized anxiety disorder: A meta-analysis of three placebo-controlled studies // Adv Ther. %u2013 2021. %u2013 Vol. 38 (3). %u2013 Pp. 1567%u20131583. %u2013https://doi.org/10.1007/s12325-020-01583-946. Slee A., Nazareth I., Bondaronek P., Liu Y., Cheng Z., Freemantle N. Pharmacological treatments for generalised anxiety disorder: A systematic review and network meta-analysis // Lancet. %u2013 2019. Vol. 393 (10173). %u2013 Pp. 768%u2013777. %u2013https://doi.org/10.1016/S0140-6736(18)31793-846. Slee A., Nazareth I., Bondaronek P., Liu Y., Cheng Z., Freemantle N. Pharmacological treatments for generalised anxiety disorder: A systematic review and network meta-analysis // Lancet. %u2013 2019. Vol. 393 (10173). %u2013 Pp. 768%u2013777. %u2013https://doi.org/10.1016/S0140-6736(18)31793-847. Quilichini J.B., Revet A., Garcia P., Bouqui%u0435%ue088 R., Hamard J., Yrondi A., Montastruc F. Comparative effects of 15 antidepressants on the risk of withdrawal syndrome: A real-world study using the WHO pharmacovigilance database // J Affect Disord. %u2013 2022. %u2013 Vol. 297. %u2013 Pp. 189%u2013193. %u2013 https://doi.org/10.1016/j.jad.2021.10.04147. Quilichini J.B., Revet A., Garcia P., Bouqui%u0435%ue088 R., Hamard J., Yrondi A., Montastruc F. Comparative effects of 15 antidepressants on the risk of withdrawal syndrome: A real-world study using the WHO pharmacovigilance database // J Affect Disord. %u2013 2022. %u2013 Vol. 297. %u2013 Pp. 189%u2013193. %u2013 https://doi.org/10.1016/j.jad.2021.10.04148. %u0425%u0430%u0441%u0430%u043d%u043e%u0432%u0430 %u0410.%u041a., %u041c%u043e%u0441%u043e%u043b%u043e%u0432 %u0421.%u041d. %u0421%u0438%u043d%u0434%u0440%u043e%u043c%u043e%u043c %u043e%u0442%u043c%u0435%u043d%u044b %u043f%u0440%u0438%u0435%u043c%u0430 %u0430%u043d%u0442%u0438%u0434%u0435%u043f%u0440%u0435%u0441%u0441%u0430%u043d%u0442%u043e%u0432 (%u0430%u043b%u0433%u043e%u0440%u0438%u0442%u043c %u043f%u0440%u043e%u0444%u0438%u043b%u0430%u043a%u0442%u0438%u043a%u0438 %u0438 %u043a%u043e%u0440%u0440%u0435%u043a%u0446%u0438%u0438) // %u0421%u043e%u0432%u0440%u0435%u043c%u0435%u043d%u043d%u0430%u044f %u0442%u0435%u0440%u0430%u043f%u0438%u044f %u043f%u0441%u0438%u0445%u0438%u0447%u0435%u0441%u043a%u0438%u0445 %u0440%u0430%u0441%u0441%u0442%u0440%u043e%u0439%u0441%u0442%u0432. %u2013 2023. %u2013 %u2116 2. %u2013 %u0421. 37%u201347. %u2013 https://doi.org/10.21265/PSYPH.2023.15.79.00548. Hasanova A.K., Mosolov S.N. Sindromom otmeny priema antidepressantov (algoritm profilaktiki i korrekcii) // Sovremennaa Terapia Psihiceskih Rasstrojstv. %u2013 2023. %u2013 %u2116 2. %u2013 S. 37%u201347. %u2013 https://doi.org/10.21265/PSYPH.2023.15.79.00549. Montejo A.L., Prieto N., de Alarc%u043e%ue088n R., Casado-Espada N., de la Iglesia J., Montejo L. Management strategies for antidepressant-related sexual dysfunction: A clinical approach // J Clin Med. %u2013 2019. %u2013 Vol. 8 (10). %u2013 Art. 1640. %u2013 https://doi.org/10.3390/jcm810164049. Montejo A.L., Prieto N., de Alarc%u043e%ue088n R., Casado-Espada N., de la Iglesia J., Montejo L. Management strategies for antidepressant-related sexual dysfunction: A clinical approach // J Clin Med. %u2013 2019. %u2013 Vol. 8 (10). %u2013 Art. 1640. %u2013 https://doi.org/10.3390/jcm810164050. %u0421%u0430%u043b%u0430%u0445%u043e%u0432%u0430 %u0410.%u0418., %u042f%u0433%u0443%u0431%u043e%u0432 %u041c.%u0418. %u0421%u0435%u043a%u0441%u0443%u0430%u043b%u044c%u043d%u0430%u044f %u0434%u0438%u0441%u0444%u0443%u043d%u043a%u0446%u0438%u044f %u043f%u0440%u0438 %u043f%u0440%u0438%u043c%u0435%u043d%u0435%u043d%u0438%u0438 %u0430%u043d%u0442%u0438%u0434%u0435%u043f%u0440%u0435%u0441%u0441%u0430%u043d%u0442%u043e%u0432 %u0443 %u043f%u0430%u0446%u0438%u0435%u043d%u0442%u043e%u0432 %u0441 %u0442%u0440%u0435%u0432%u043e%u0436%u043d%u044b%u043c%u0438 %u0438 %u0434%u0435%u043f%u0440%u0435%u0441%u0441%u0438%u0432%u043d%u044b%u043c%u0438 %u0440%u0430%u0441%u0441%u0442%u0440%u043e%u0439%u0441%u0442%u0432%u0430%u043c%u0438 (%u0430%u043b%u0433%u043e%u0440%u0438%u0442%u043c %u0432%u0435%u0434%u0435%u043d%u0438%u044f %u0438 %u043a%u043e%u0440%u0440%u0435%u043a%u0446%u0438%u0438) // %u0421%u043e%u0432%u0440%u0435%u043c%u0435%u043d%u043d%u0430%u044f %u0442%u0435%u0440%u0430%u043f%u0438%u044f %u043f%u0441%u0438%u0445%u0438%u0447%u0435%u0441%u043a%u0438%u0445 %u0440%u0430%u0441%u0441%u0442%u0440%u043e%u0439%u0441%u0442%u0432. %u2013 2024. %u2013 %u2116 2. %u2013 %u0421. 56%u201367. %u2013 https://doi.org/10.21265/PSYPH.2024.31.31.00650. Salahova A.I., Jagubov M.I. Seksual%u2019naja disfunkcija pri primenenii antidepressantov u pacientov s trevozhnymi i depressivnymi rasstrojstvami (algoritm vedenija i korrekcii) // Sovremennaa Terapia Psihiceskih Rasstrojstv. %u2013 2024. %u2013 %u2116 2. %u2013 S. 56%u201367. %u2013 https://doi.org/10.21265/PSYPH.2024.31.31.006